An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma (NPC): Preliminary report.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 5577-5577
◽
2011 ◽
Vol 47
◽
pp. S561
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. e17020-e17020
◽
2020 ◽
Vol 108
(3)
◽
pp. e839
2010 ◽
Vol 77
(2)
◽
pp. 617-621
◽
2020 ◽
Vol 108
(3)
◽
pp. e819